Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study
-
Published:2024-10
Issue:
Volume:77
Page:103780
-
ISSN:0960-9776
-
Container-title:The Breast
-
language:en
-
Short-container-title:The Breast
Author:
Alés-Martínez José Enrique,
Balmaña Judith,
Sánchez-Rovira Pedro,
Salvador Bofill Francisco Javier,
García Sáenz Jose ÁngelORCID,
Pimentel Isabel,
Morales Serafín,
Fernández-Abad MaríaORCID,
Lahuerta Martínez AinharaORCID,
Ferrer Neus,
Zamora PilarORCID,
Bermejo BegoñaORCID,
Díaz-Redondo Tamara,
López-Ceballos María Helena,
Galán María,
Pérez-Escuredo JhuditORCID,
Calabuig Laura,
Sampayo Miguel,
Pérez-Garcia José Manuel,
Cortés JavierORCID,
Llombart-Cussac Antonio